Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) EBT Margin (2016 - 2025)

Avanos Medical's EBT Margin history spans 11 years, with the latest figure at 5.58% for Q3 2024.

  • For Q3 2024, EBT Margin rose 709.0% year-over-year to 5.58%; the TTM value through Sep 2024 reached 3.83%, up 422.0%, while the annual FY2023 figure was 1.17%, 508.0% down from the prior year.
  • EBT Margin for Q3 2024 was 5.58% at Avanos Medical, up from 3.61% in the prior quarter.
  • Across five years, EBT Margin topped out at 9.97% in Q4 2022 and bottomed at 64.53% in Q4 2021.
  • The 5-year median for EBT Margin is 1.52% (2023), against an average of 3.98%.
  • The largest annual shift saw EBT Margin crashed -3761bps in 2021 before it soared 7449bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 26.92% in 2020, then crashed by -140bps to 64.53% in 2021, then surged by 115bps to 9.97% in 2022, then crashed by -48bps to 5.14% in 2023, then grew by 9bps to 5.58% in 2024.
  • Per Business Quant, the three most recent readings for AVNS's EBT Margin are 5.58% (Q3 2024), 3.61% (Q2 2024), and 0.9% (Q1 2024).